secwatch.observer — SEC 8-K summary
======================================

Issuer:     Barinthus Biotherapeutics plc. (BRNS)
CIK:        0001828185
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001104659-24-097364
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Barinthus Biotherapeutics promotes Graham Griffiths to COO effective Sept 1, 2024
--------------------------------------------------------------------------------

- Graham Griffiths promoted from Chief Business Officer to COO, effective Sept 1, 2024.
- Salary increased to £336,144 in connection with the promotion.
- Griffiths joined Barinthus in Oct 2017; previously COO and co-founder of Agalimmune Ltd.
- No related party transactions or family relationships with directors or officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828185/000110465924097364/0001104659-24-097364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828185/000110465924097364/tm2423440d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-097364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer